236
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease

, MD PhD, , , , , & show all
Pages 2599-2604 | Published online: 15 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Miao Hu & Brian Tomlinson. (2013) Current Perspectives on rosuvastatin. Integrated Blood Pressure Control 6, pages 15-25.
Read now

Articles from other publishers (4)

Leonardo CalzaRoberto ManfrediVincenzo ColangeliFabio Filippo TrapaniCaterina SalvadoriEleonora MagistrelliIlaria DaneseGabriella VerucchiCarla SerraPierluigi Viale. (2013) Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk. AIDS Research and Human Retroviruses 29:3, pages 547-556.
Crossref
Kirstie K. Danielson, Betul Hatipoglu, Katie Kinzer, Bruce Kaplan, Joan Martellotto, Meirigeng Qi, Alessandra Mele, Enrico Benedetti & José Oberholzer. (2013) Reduction in Carotid Intima-Media Thickness After Pancreatic Islet Transplantation in Patients With Type 1 Diabetes. Diabetes Care 36:2, pages 450-456.
Crossref
Kosmas I. Paraskevas, Christos D. Liapis & Frank J. Veith. (2012) Identifying Asymptomatic Carotid Stenosis Patients at High Risk of Cerebrovascular Events. Angiology 63:7, pages 489-491.
Crossref
Cheol Whan Lee, Su-Jin Kang, Jung-Min Ahn, Hae Geun Song, Jong-Young Lee, Won-Jang Kim, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, Seong-Wook Park & Seung-Jung Park. (2012) Comparison of Effects of Atorvastatin (20 mg) Versus Rosuvastatin (10 mg) Therapy on Mild Coronary Atherosclerotic Plaques (from the ARTMAP Trial). The American Journal of Cardiology 109:12, pages 1700-1704.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.